Insulin Pump to Multiple Daily Injection Transition Clinical Trial
NCT03987191
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes
Interventions
DRUG:
Multiple daily ijnection using Insulin Degludec and Insulin Aspart
Sponsor
University of Colorado, Denver